A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer

NCT02501278 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NETWORK

Sponsor class

Stopped company (Inovio) is no longer able to support the study

Conditions

Uterine Cervical Neoplasms

Interventions

BIOLOGICAL: INO-3112 vaccine
RADIATION: Radiotherapy (Extrernal beam radiotherapy + brachytherapy)
DRUG: Cisplatin chemotherapy

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]
[object Object]